PUMA BIOTECHNOLOGY, INC. (PBYI) Shareholders’ equity 2017–2025
PUMA BIOTECHNOLOGY, INC. (PBYI) shareholders’ equity at each fiscal year-end, per SEC filings.
$130.3MFY2025 · since FY2017: $53.3M → $130.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $130.3M | +41.5% |
| FY2024 | $92.1M | +72.4% |
| FY2023 | $53.4M | +147.3% |
| FY2022 | $21.6M | +983.4% |
| FY2021 | -$2.4M | +58.9% |
| FY2020 | -$6.0M | -134.1% |
| FY2019 | $17.5M | -49.1% |
| FY2018 | $34.3M | -35.6% |
| FY2017 | $53.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice